Forbes has an investment letter that they tease on their site. Right now they are teasing 12 top stocks. Does anyone subscribe to them? I’d be interested to know the stocks and reasons. Are they just regurgitating large cap picks or do they have some smart SMID picks?
Leave a comment Read MoreArticles
Forbes Top 12 Stocks
Forbes Investor
Forbes Low-Priced Stock Report
High-Yield(ish) Canadian Buys from Gordon Pape
I often find myself getting stuck in a rut writing about the same folks over and over — the Motley Fool guys, the various Agora offspring (Stansberry, Angel, etc.), Robert Hsu and Louis Navellier and their Investorplace colleagues come up over and over, largely because they’re the ones who push the most aggressive teasers … […]
8 Comments Read MoreSpecial Situation Survey
Forbes: “Emerging Market Stocks You Must Own Now!”
The folks at Forbes are out with a new investing newsletter, the aptly titled International Stock Advisory by John Christy. Doesn’t have a track record yet, of course, but at least they’re doing a little teasing about their favorite stocks … so the Gumshoe is on the case! The newsletter will run you about $200 […]
1 Comment Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I suggest Gumshoe readers Google this article from Forbes 12-15-22: “The World’s Most Important Product and the On...
I too got Prins' "Disruption Report" after Bonner and his crew left Rogue Economics. Yesterday I received another emai...
This might be it!Google keywords “forbes ajherrington startup company metaverse” to find the article in referenc...
Link above to the Forbes article is wrong, it goes to a Wired article on Fastly....
Found this old piece (May, 2019) in Forbes written by the same Bob Carlson, sounding a much less alarming tone, possibl...
It seems he is touting the Blockchain revolution. In particular this is investing in ETF's that invest in various compa...
I'm a little surprised to hear that about Bottom Line. My father subscribed to their newsletter. He was a voracious ...
in the TEEKA TIWARI’S “GENESIS” video, I thought for sure the first stock was Credit Suisse asset (CIK) because it...
Hi Gordie, welcome to our space and thanks for commenting... yes, the promoters often try to add gravitas by including m...
Is there an update on the Nasdaq cryptocurrency? The latest thing I've been able to dig up on this was an article by a F...
I've never heard of that particular one, but "a cure for every cancer" is exceedingly unlikely. A tiny bit of digging ...
Even back in July 2018, Forbes had an article quoting Terry Gou (head of Foxconn) stating that his goal for stock price ...
They know more that the business inside and out the ceo was the original ceo of canopy the list of as they refer to it a...
I agree with your first comment completely. Forbes I'm not familiar with judging that they are a financial mag and the l...
In fact, an article in Forbes magazine states "In reality, the EWG, which has been dubbed the Environmental Worry Group,...
Lots of good info from EndPoints: NEW Judgment day is coming: Federal judge orders Martin Shkreli to forfeit a small ...
So far all I can find is that after raising $850 billion they decided to have a second private ico round. While they wer...
$CWBR#MindBlowing#Thank you Dr. KSS: Excellent Article: Forbes Magazine: "The Cult of DNA-centricity"https://www.for...
$NVS, GWPH...$SGYP Needs to raise $25-30m in cash by Jan 31st. Debt covenant shows they need $128m of cash Jan 31s...
$ESPR re: today's 10%+ share price decline (ouch) three possible culprits . 1) sharp pullback from a fairly torrid rise...
$ONCE, $PFE... NEW http://e.endpointsnews.com/t/ViewEmail/t/09E2A4F6D4C4E999/2F80028A944F69C925D77A725F39070EPark...
No experience with customer service, hence voted only on the other items. Best for analysis & quality of writing., w...
Travis Good afternoon. Have you looked at Wealthy Retirement touting "Impossible Matter" Found on Jupiter Could Cut Elec...
1 Stock to Buy for the Return of "iPhone Mania" iPhone madness is back. And one little known company is allowing Apple t...
$NVS - Was surprised I was the first to post about this, but double-checked and saw the above link from rfyjr.I add...
$AUPHHI Denny, just a quick answer to your question. Please be reminded that the ParabolicSAR matrix is a "moving ta...
$AUPH's major shareholder: Robert DugganFeatured in Forbes: https://www.forbes.com/profile/robert-duggan/Best, H...
That's an interesting form of prevarication, especially in light of something I read just the other day by a former Forb...
you have to watch those money back guarantees. Forbes got me to sign up for one of their investment newsletters. The pre...
ABEO with some good ink in Forbes article. This may be one I have to squeeze in portfolio down the road. https://www.fo...
Sharon, I have created a .pdf file of the Forbes article, if someone can tell be how to do it, I will upload it or send ...
$no ticker. Danmcco, I don't know if its the Forbes website, but I tried various methods to get to the site without su...
In my opinion, Weiss has missed many investment returns because they seem to favor Conservative Republicans when histor...
$AKAO $AKBAAn interesting article from Forbes, just in:"Four stocks moving both on the news and the charts" ...
$BIOC - This may be a new Forbes article, but the news goes back to last year and has been commented on here in the past...
Do you ever wonder how all those politicians arrive in Washington with "regular" wealth, earn $174,000 a year for a few ...
$SCYX (long)Great article, Doc - and very timely. The controversial clinical hold action in this case exemplifies t...
https://www.axios.com/business-media-has-its-own-fake-news-problem-2353912512.htmlMany already know this, but for th...
Interesting Article in Forbes tonight about Amgen and ESPR mentioned. Here the link https://www.forbes.com/sites/davidg...
$ESPR: Basically, all the arguments in the articles I read today (NEJM, Forbes, IBD et all.) were alluded to in my fir...
$ESPRNew Forbes article on this subject, just in:"Amgen drug prevents heart attacks, not deaths, disappointing e...
Thank YOU for the kind comments, Tony.While Twitter is very speedy, you are correct that the noise-to-signal (sic) r...
A Complete Beginner's Guide To #Blockchain via @forbes http://www.forbes.com/sites/bernardmarr/2017/01/24/a-complete-b...
Hi Cleveland, Can you research $CYDY finances, will they have to raise equity before completion of HIV Tx. Pro140 Phase...
Related to this, an interesting proposal out of Forbes today advocating for the U.S government to buy Gilead to the tune...
Seems our little AUPH made the Forbes Dean's list for 2017 as a big idea. Great ink for them because Forbes reach's a lo...
Once again thanks for your candor and thoroughness. The Forbes Billionaire Portfolio ad was enticing, but aren't they al...
Does anyone have experience with Forbes Billionaire Portfolio newsletter. Sounds intriguing but don't they all!...
I've been tuning in to updates from the Forbes 2016 Healthcare Summit in the hope many of the big players attending woul...
Came across this in Forbes on gold. What's a person to do? Check out this link on gold http://www.forbes.com/sites/johnw...
Here is a Forbes article to illustrate my point:http://www.forbes.com/sites/wallaceforbes/2015/04/28/6-smid-caps-wit...
Forbes: Innovative Companies: http://www.forbes.com/innovative-companies/#79707158f172...
$ESPR, $AMGN, $SNY, $PFE New Atherosclerosis Study Results Bode Well For PCSK-9 Cholesterol-Lowering DrugsJohn LaMa...
PTLA, KITE, BLUE, INCY mentioned in this Forbes article as possible take over candidates.http://www.forbes.com/sites...
Travis Off topic. I don't know how to submit this for your perusal, so am posting it here in case you want to do a tea...
Travis, I am one of Jim Rickards' subscribers so I can tell you that his "World Money" play is actually something you w...
Forbes was writing about "Deep Learning And Machine Intelligence " in an article dating to 2014. http://www.forbes.com/s...
Here is discussion which includes a Forbes article and links describing ETC, ETH, the hard fork and Kraken. http://ww...
http://www.forbes.com/sites/anthonykosner/2014/12/29/tech-2015-deep-learning-and-machine-intelligence-will-eat-the-world...
$ESPR http://www.esperion.com/note-from-our-ceo/This is Tim Mayleben – CEO of Esperion Therapeutics with some tho...
Juno: ''Remarkably, Juno gave the news about the hold to Forbes writers ahead of the announcement.'' That sounds like tr...
How Deep Learning Networks Can Use Virtual Worlds To Solve Real World Problems - Forbes http://buff.ly/1Nl23dW #ai htt...
How Deep Learning Networks Can Use Virtual Worlds To Solve Real World Problems - Forbes http://buff.ly/1Nl23dW #ai...
Will leave comment on this article to the experts here, but interestingly did just read this article from Forbes on fili...
Forbes article on how GILD can double in 3 years. http://www.forbes.com/sites/kenkam/2016/04/15/gild-future-biotech-fun...
From Forbes -- the largest biotech you never heard of... http://www.forbes.com/sites/matthewherper/2016/04/13/the-god-p...
Travis 2.1 billion Zuckerburg is NVDA tease based Zucks investment in Virtual Reality.Forbes just released their ann...
Forbes article with ESPR mentioned.http://www.forbes.com/sites/matthewherper/2016/04/03/some-people-really-cant-take...
No, he really did mean Unum Therapeutics. It's a private CAR-T variant play that has been financed by venture capitalist...
Forbes Names Cannabis CEO to Prominent List: http://mjbizdaily.com/forbes-names-cannabis-ceo-to-prominent-list/ Best2A...
In July 2015, Forbes reported on twitter, "It’s safe to say that cloud computing is the next “big thing.”http...
Back to the title article, from Forbes we get: Want to Fight a Deadly Fungus? San Diego's Amplyx Just Got $41M For That...
That Forbes list link led to only five stocks, and the timeline under each was for 2011. Heartland Payment Systems HPY ...
Investors have lost literally hundreds of thousands getting into such "ground-floor" companies. Without understanding wh...
GILD mentioned as blue chip bargain by Forbes. http://forbesmags.com/slp/blue_chip_oct15.pdfCheers,Glenn...
The Future Of Medicine -- Where Investors Are Putting Their Money: http://www.forbes.com/sites/realspin/2015/05/01/the-...
Glenn: I came across that article too, it's pretty lame--he has a cursory at best knowledge of these companies, but it's...
Forgot to mention PTLA was mentioned in Forbes article as well. Cheers,Glenn...
ZFGN and ESPR mentioned in Forbes article. http://www.forbes.com/sites/greatspeculations/2015/10/09/biogen-and-four-oth...
$ESPR Forbes Pharma & HealthcareAmgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will ...
Forbes Pharma & Healthcare - David Sable, Contributor Five Reasons Why Your Biotech Comparative Value Theory Is Wrong ...
From John LaMattina @ Forbes: Will Alnylam's New PCSK-9 Cholesterol Lowering Drug Be A Blockbuster?"before christen...
Interesting article in Forbes: When Doctors Invest: Dumb Mistakes And Offsetting Advantages By David Sable , Contrib...
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing BattlesJohn LaMattina , Contributor I cover news on d...
Interesting Forbes article on NDA's and approvals. http://www.forbes.com/sites/matthewherper/2015/08/25/nine-explanatio...
Forbes on PTN -- take your profit and run: http://www.forbes.com/sites/johnlamattina/2015/08/18/you-can-call-it-the-fem...
Forbes point of view on patient death in KITE trial. http://www.forbes.com/sites/matthewherper/2015/08/17/patient-death...
Just watched the Theranos TED talk yesterday--most interestingIt is private company. They have already raised $400 m...
Read an article in my Forbes magazine, Issue July 20 regarding Docker. Assume that is the business you are referring ...
Forbes view on JUNO/CELGENE deal. http://www.forbes.com/sites/stephenbrozak/2015/06/30/did-celgenes-billion-dollar-deal...
ESPRThis from Forbes (not that positive about Esperion)Why Esperion Shares Are Down 18% TodayShares of Esper...
I see this Forbes article from Matt saying $ESPR needs to worry since they may need large trials.http://www.forbes.c...
Interesting and very public battle going on about this drug, and the issues are at least as much politics and perception...
There's only a fixed number of services that they remarket over and over with different copywriting. Occasionally they ...
Forbes Biotech report. http://www.forbes.com/sites/luketimmerman/2015/05/23/what-you-may-have-missed-in-biotech-eye-dru...
ESPR Chardan managed to get lame hit piece into Forbes: http://blogs.barrons.com/stockstowatchtoday/2015/05/22/esperio...
$LNEGY Siluria (wi) news article 10 days ago in Forbes sez Paul Allen of Vulcan Capital is now in Siluria and they i...
Great story written today at Forbes on Immune system combo drugs to fight cancer. http://www.forbes.com/sites/matthewhe...
If you haven't seen the currently running 3-part Cancer series on PBS, I recommend you catch it. Part 2 tonight and p3 t...